Endothelial microparticles in diseases

[1]  W. Grossman,et al.  Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. , 2008, American journal of respiratory and critical care medicine.

[2]  S. Glantz,et al.  Brief secondhand smoke exposure depresses endothelial progenitor cells activity and endothelial function: sustained vascular injury and blunted nitric oxide production. , 2008, Journal of the American College of Cardiology.

[3]  J. Freyssinet,et al.  Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. , 2008, American journal of respiratory and critical care medicine.

[4]  A. Simon,et al.  Impact of shear stimulus, risk factor burden and early atherosclerosis on the time-course of brachial artery flow-mediated vasodilation , 2008, Journal of hypertension.

[5]  Gilles Chironi,et al.  Comparative performance of subclinical atherosclerosis tests in predicting coronary heart disease in asymptomatic individuals. , 2007, European heart journal.

[6]  Jiemei Wang,et al.  Increased circulating CD31+/CD42- microparticles are associated with impaired systemic artery elasticity in healthy subjects. , 2007, American journal of hypertension.

[7]  G. Schillaci,et al.  Endothelial microparticles and arterial stiffness: casual coincidence or causative culprit? , 2007, American Journal of Hypertension.

[8]  C. Lindsell,et al.  Endothelial microparticle levels are similar in acute ischemic stroke and stroke mimics due to activation and not apoptosis/necrosis. , 2007, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[9]  A. Piccin,et al.  Circulating microparticles: pathophysiology and clinical implications. , 2007, Blood reviews.

[10]  P. Landsbergis,et al.  Stopping stress at its origins: addressing working conditions. , 2007, Hypertension.

[11]  G. London,et al.  In Vivo Shear Stress Determines Circulating Levels of Endothelial Microparticles in End-Stage Renal Disease , 2007, Hypertension.

[12]  Jiemei Wang,et al.  C-Reactive Protein-Induced Endothelial Microparticle Generation in HUVECs Is Related to BH4-Dependent NO Formation , 2007, Journal of Vascular Research.

[13]  D. Giugliano,et al.  Endothelial microparticles correlate with erectile dysfunction in diabetic men , 2007, International Journal of Impotence Research.

[14]  Y. Castier,et al.  Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. , 2007, Journal of the American College of Cardiology.

[15]  A. Simon,et al.  Circulating Leukocyte-Derived Microparticles Predict Subclinical Atherosclerosis Burden in Asymptomatic Subjects , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[16]  A. Stamatoullas,et al.  Outcome of Treatment after First Relapse in Adults Patients with Acute Lymphoblastic Leukemia (ALL) Initially Treated by the LALA-94 Trial. , 2006 .

[17]  B. Loriod,et al.  Thrombin-induced endothelial microparticle generation: identification of a novel pathway involving ROCK-II activation by caspase-2. , 2006, Blood.

[18]  Gilles Chironi,et al.  Performance of Subclinical Arterial Disease Detection as a Screening Test for Coronary Heart Disease , 2006, Hypertension.

[19]  D. Giugliano,et al.  Endothelial microparticles correlate with endothelial dysfunction in obese women. , 2006, The Journal of clinical endocrinology and metabolism.

[20]  A. Tedgui,et al.  Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. , 2006, Hypertension.

[21]  L. Horstman,et al.  Endothelial microparticles and platelet and leukocyte activation in patients with the metabolic syndrome. , 2006, The American journal of cardiology.

[22]  V. Faure,et al.  Elevation of circulating endothelial microparticles in patients with chronic renal failure , 2006, Journal of thrombosis and haemostasis : JTH.

[23]  Chantal M Boulanger,et al.  Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure. , 2005, Journal of the American Society of Nephrology : JASN.

[24]  R. Schein,et al.  Levels of endothelial and platelet microparticles and their interactions with leukocytes negatively correlate with organ dysfunction and predict mortality in severe sepsis , 2005, Critical care medicine.

[25]  L. Horstman,et al.  Endothelial microparticles induce formation of platelet aggregates via a von Willebrand factor/ristocetin dependent pathway, rendering them resistant to dissociation , 2005, Journal of thrombosis and haemostasis : JTH.

[26]  Tomohiro Sakamoto,et al.  Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. , 2005, Journal of the American College of Cardiology.

[27]  J. Freyssinet,et al.  Circulating Cell-Derived Microparticles in Crohn’s Disease , 2005, Digestive Diseases and Sciences.

[28]  K. Fukudome,et al.  Activated protein C induces the release of microparticle-associated endothelial protein C receptor. , 2005, Blood.

[29]  J. Freyssinet,et al.  Membrane microparticles: two sides of the coin. , 2005, Physiology.

[30]  R. Nieuwland,et al.  Cellular microparticles: new players in the field of vascular disease? , 2004, European journal of clinical investigation.

[31]  N. Young,et al.  Elevated circulating endothelial membrane microparticles in paroxysmal nocturnal haemoglobinuria , 2004, British journal of haematology.

[32]  D. Mant,et al.  Endothelial and platelet microparticles in vasculitis of the young. , 2004, Arthritis and rheumatism.

[33]  R. Nieuwland,et al.  Antigenic characterization of endothelial cell‐derived microparticles and their detection ex vivo , 2003, Journal of thrombosis and haemostasis : JTH.

[34]  R. Hebbel,et al.  Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. , 2003, Blood.

[35]  R. Nieuwland,et al.  Microparticles in cardiovascular diseases. , 2003, Cardiovascular research.

[36]  L. Horstman,et al.  High levels of circulating endothelial microparticles in patients with acute coronary syndromes. , 2003, American heart journal.

[37]  L. Horstman,et al.  Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. , 2003, Thrombosis research.

[38]  Richard A. Preston,et al.  Effects of Severe Hypertension on Endothelial and Platelet Microparticles , 2003, Hypertension.

[39]  R. Nieuwland,et al.  Elevated Numbers of Tissue-Factor Exposing Microparticles Correlate With Components of the Metabolic Syndrome in Uncomplicated Type 2 Diabetes Mellitus , 2002, Circulation.

[40]  Patrice Darmon,et al.  Type 1 and type 2 diabetic patients display different patterns of cellular microparticles. , 2002, Diabetes.

[41]  A. Tedgui,et al.  Circulating Microparticles From Patients With Myocardial Infarction Cause Endothelial Dysfunction , 2001, Circulation.

[42]  A. Zeiher,et al.  Vitamin C Inhibits Endothelial Cell Apoptosis in Congestive Heart Failure , 2001, Circulation.

[43]  R. Weisel,et al.  Enhanced Myocardial Angiogenesis by Gene Transfer With Transplanted Cells , 2001, Circulation.

[44]  A. Minagar,et al.  Elevated plasma endothelial microparticles in multiple sclerosis , 2001, Neurology.

[45]  C. Hack,et al.  Cell-derived Microparticles Circulate in Healthy Humans and Support Low Grade Thrombin Generation , 2001, Thrombosis and Haemostasis.

[46]  L. Horstman,et al.  Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease , 2001, British journal of haematology.

[47]  A. Zeiher,et al.  Congestive heart failure induces endothelial cell apoptosis: protective role of carvedilol. , 2000, Journal of the American College of Cardiology.

[48]  J. Freyssinet,et al.  Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. , 2000, Circulation.

[49]  G. Grau,et al.  In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. , 1999, The Journal of clinical investigation.

[50]  J. Freyssinet,et al.  Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. , 1999, Circulation.

[51]  L. Horstman,et al.  Elevated platelet microparticles in transient ischemic attacks, lacunar infarcts, and multiinfarct dementias. , 1993, Thrombosis research.

[52]  S. Karpatkin,et al.  Microthrombocytosis and Platelet Fragmentation Associated with Idiopathic/Autoimmune Thrombocytopenic Purpura , 1975, British journal of haematology.

[53]  B. Warren,et al.  The release of vesicles from platelets following adhesion to vessel walls in vitro. , 1972, British journal of experimental pathology.

[54]  P. Wolf.  The Nature and Significance of Platelet Products in Human Plasma , 1967, British journal of haematology.

[55]  J. R. O'brien.  The Platelet‐like Activity of Serum. , 1955, British journal of haematology.

[56]  E. Chargaff,et al.  The biological significance of the thromboplastic protein of blood. , 1946, The Journal of biological chemistry.

[57]  Miguel Ángel Martínez,et al.  Proteomic analysis of malignant lymphocyte membrane microparticles using double ionization coverage optimization , 2006, Proteomics.

[58]  F. Dignat-George,et al.  Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome , 2004, Thrombosis and Haemostasis.

[59]  A. Karsan,et al.  Apoptotic vascular endothelial cells become procoagulant. , 1997, Blood.